Development of a Genetic Counseling Patient Preference Intervention for Women at Elevated Risk for Breast Cancer

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05158452

Enrollment

Registered

2021-12-15

Start date

2020-12-09

Completion date

2022-10-30

Last updated

2022-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Carcinoma

Brief summary

This study develops a genetic counseling patient preference intervention for women at elevated risk for breast cancer. This study aims to develop an intervention that may deliver educational videos about breast cancer, heredity, multigene tests results and polygenic risk score, provide multigene and polygenic test results, obtain information about patients' questions/ concerns about test results to use in post-genetic test counseling, and determine patient preference (e.g. telephone) for receipt of post-genetic test counseling.

Detailed description

PRIMARY OBJECTIVE: I. Develop the Genetic Counseling Patient Preference (GCPP) intervention in collaboration with community members. OUTLINE: Participants attend a focus group over 90-120 minutes providing feedback on GCPP intervention.

Interventions

PROCEDUREDiscussion

Attend a focus group

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

35 Years to 64 Years

Healthy volunteers

Inclusion criteria

* Female * Ages 35-64 * Known elevated risk for breast cancer * The ability to speak and read English * Provide written consent

Design outcomes

Primary

Measure	Time frame
Development of Genetic Counseling Patient Preference (GCPP) intervention	Up to 2 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026